Protein arginine methylation: a new handle on T lymphocytes?

Trends in Immunology

Volumn 31, Issue 4, 2010, Pages 164-169

  Parry, Richard V ^a   Ward, Stephen G ^a  

^a University of Bath   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSYLHOMOCYSTEINASE INHIBITOR; ARGININE; CYCLOSPORIN A; TRANSCRIPTION FACTOR;

AUTOIMMUNE DISEASE; GRAFT REJECTION; HUMAN; IMMUNOTHERAPY; INFLAMMATION; NONHUMAN; PROTEIN METHYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ARGININE; CHROMOSOMAL PROTEINS, NON-HISTONE; HUMANS; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; METHYLATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 77950189497     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2010.01.006     Document Type: Review

References (42)

1. Najbauer J., et al. Peptides with sequences similar to glycine, arginine-rich motifs in proteins interacting with RNA are efficiently recognized by methyltransferase(s) modifying arginine in numerous proteins. J. Biol. Chem. 268 (1993) 10501-10509
2. Ong S.E., et al. Identifying and quantifying in vivo methylation sites by heavy methyl SILAC. Nat. Methods 1 (2004) 119-126
3. Herrmann F., et al. Human protein arginine methyltransferases in vivo--distinct properties of eight canonical members of the PRMT family. J. Cell. Sci. 122 (2009) 667-677
4. Donofrio J., et al. Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease. J. Clin. Invest. 62 (1978) 884-887
5. Hershfield M.S., Kredich N.M., Ownby D.R., Ownby H., and Buckley R. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients. J. Clin. Invest. 63 (1979) 807-811
6. Chiang P.K. S-adenosylhomocysteine hydrolase as a pharmacological target for the inhibition of transmethylation. Adv. Exp. Med. Biol. 165 Pt B (1984) 199-203
7. Borchardt R.T. S-Adenosyl-L-methionine-dependent macromolecule methyltransferases: potential targets for the design of chemotherapeutic agents. J. Med. Chem. 23 (1980) 347-357
8. Blaese R.M., Culver K.W., Miller A.D., Carter C.S., Fleisher T., Clerici M., Shearer G., Chang L., Chiang Y., Tolstoshev P., Greenblatt J.J., Rosenberg S.A., Klein H., Berger M., Mullen C.A., Ramsey W.J., Muul L., Morgan R.A., and Anderson W.F. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 270 (1995) 475-480
9. Cassani B., Mirolo M., Cattaneo F., Benninghoff U., Hershfield M., Carlucci F., Tabucchi A., Bordignon C., Roncarolo M.G., and Aiuti A. Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients. Blood 111 (2008) 4209-4219
10. Bedford M.T., and Clarke S.G. Protein arginine methylation in mammals: who, what, and why. Mol. Cell 33 (2009) 1-13
11. Kim J., Lee J., Yadav N., Wu Q., Carter C., Richard S., Richie E., and Bedford M.T. Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early T cell development. J. Biol. Chem. 279 (2004) 25339-25344
12. Blanchet F., Cardona A., Letimier F.A., Hershfield M.S., and Acuto O. CD28 costimulatory signal induces protein arginine methylation in T cells. J. Exp. Med. 202 (2005) 371-377
13. Houlard M., Arudchandran R., Regnier-Ricard F., Germani A., Gisselbrecht S., Blank U., Rivera J., and Varin-Blank N. Vav1 is a component of transcriptionally active complexes. J. Exp. Med. 195 (2002) 1115-1127
14. Lawson B.R., Manenkova Y., Ahamed J., Chen X., Zou J.P., Baccala R., Theofilopoulos A.N., and Yuan C. Inhibition of transmethylation down-regulates CD4 T cell activation and curtails development of autoimmunity in a model system. J. Immunol. 178 (2007) 5366-5374
15. Sanchez-Margalet V., and Najib S. p68 Sam is a substrate of the insulin receptor and associates with the SH2 domains of p85 PI3K. FEBS Lett. 455 (1999) 307-310
16. Le Romancer M., Treilleux I., Leconte N., Robin-Lespinasse Y., Sentis S., Bouchekioua-Bouzaghou K., Goddard S., Gobert-Gosse S., and Corbo L. Regulation of estrogen rapid signaling through arginine methylation by PRMT1. Mol. Cell 31 (2008) 212-221
17. Wolos J.A., Frondorf K.A., Davis G.F., Jarvi E.T., McCarthy J.R., and Bowlin T.L. Selective inhibition of T cell activation by an inhibitor of S-adenosyl-L-homocysteine hydrolase. J. Immunol. 150 (1993) 3264-3273
18. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
19. Gilley J., Coffer P.J., and Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J. Cell Biol. 162 (2003) 613-622
20. Kerdiles Y.M., Beisner D.R., Tinoco R., Dejean A.S., Castrillon D.H., DePinho R.A., and Hedrick S.M. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat. Immunol. 10 (2009) 176-184
21. Yamagata K., Daitoku H., Takahashi Y., Namiki K., Hisatake K., Kako K., Mukai H., Kasuya Y., and Fukamizu A. Arginine methylation of FOXO transcription factors inhibits their phosphorylation by Akt. Mol. Cell 32 (2008) 221-231
22. Clipstone N.A., and Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357 (1992) 695-697
23. Peng S.L., Gerth A.J., Ranger A.M., and Glimcher L.H. NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity 14 (2001) 13-20
24. Hodge M.R., Ranger A.M., Charles de la Brousse F., Hoey T., Grusby M.J., and Glimcher L.H. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4 (1996) 397-405
25. Mowen K.A., Schurter B.T., Fathman J.W., David M., and Glimcher L.H. Arginine methylation of NIP45 modulates cytokine gene expression in effector T lymphocytes. Mol. Cell 15 (2004) 559-571
26. Schindler C., Levy D.E., and Decker T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282 (2007) 20059-20063
27. Shuai K., and Liu B. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat. Rev. Immunol. 5 (2005) 593-605
28. Mowen K.A., Tang J., Zhu W., Schurter B.T., Shuai K., Herschman H.R., and David M. Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104 (2001) 731-741
29. Weber S., Maass F., Schuemann M., Krause E., Suske G., and Bauer U.M. PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling. Genes Dev. 23 (2009) 118-132
30. Komyod W., Bauer U.M., Heinrich P.C., Haan S., and Behrmann I. Are STATS arginine-methylated?. J. Biol. Chem. 280 (2005) 21700-21705
31. Chen W., Daines M.O., and Hershey G.K. Methylation of STAT6 modulates STAT6 phosphorylation, nuclear translocation, and DNA-binding activity. J. Immunol. 172 (2004) 6744-6750
32. Fu Y.F., Zhu Y.N., Ni J., Zhong X.G., Tang W., Re Y.D., Shi L.P., Wan J., Yang Y.F., Yuan C., Nan F.J., Lawson B.R., and Zuo J.P. A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation. J. Pharmacol. Exp. Ther. 319 (2006) 799-808
33. Prisco A., Vanes L., Ruf S., Trigueros C., and Tybulewicz V.L. Lineage-specific requirement for the PH domain of Vav1 in the activation of CD4+ but not CD8+ T cells. Immunity 23 (2005) 263-274
34. Wolos J.A., Frondorf K.A., and Esser R.E. Immunosuppression mediated by an inhibitor of S-adenosyl-L-homocysteine hydrolase. Prevention and treatment of collagen-induced arthritis. J. Immunol. 151 (1993) 526-534
35. Parkinson J.S., Ames P., and Studdert C.A. Collaborative signaling by bacterial chemoreceptors. Curr. Opin. Microbiol. 8 (2005) 116-121
36. Vedel M., Lawrence F., Robert-Gero M., and Lederer E. The antifungal antibiotic sinefungin as a very active inhibitor of methyltransferases and of the transformation of chick embryo fibroblasts by Rous sarcoma virus. Biochem. Biophys Res. Commun. 85 (1978) 371-376
37. Cheng D., Yadav N., King R.W., Swanson M.S., Weinstein E.J., and Bedford M.T. Small molecule regulators of protein arginine methyltransferases. J. Biol. Chem. 279 (2004) 23892-23899
38. Spannhoff A., Heinke R., Bauer I., Trojer P., Metzger E., Gust R., Schule R., Brosch G., Sippl W., and Jung M. Target-based approach to inhibitors of histone arginine methyltransferases. J. Med. Chem. 50 (2007) 2319-2325
39. Spannhoff A., Machmur R., Heinke R., Trojer P., Bauer I., Brosch G., Schule R., Hanefeld W., Sippl W., and Jung M. A novel arginine methyltransferase inhibitor with cellular activity. Bioorg. Med. Chem. Lett. 17 (2007) 4150-4153
40. Allan M., Manku S., Therrien E., Nguyen N., Styhler S., Robert M.F., Goulet A.C., Petschner A.J., Rahil G., Robert Macleod A., Deziel R., Besterman J.M., Nguyen H., and Wahhab A. N-Benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1). Bioorg. Med. Chem. Lett. 19 (2009) 1218-1223
41. Huynh T., Chen Z., Pang S., Geng J., Bandiera T., Bindi S., Vianello P., Roletto F., Thieffine S., Galvani A., Vaccaro W., Poss M.A., Trainor G.L., Lorenzi M.V., Gottardis M., Jayaraman L., and Purandare A.V. Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1). Bioorg. Med. Chem. Lett. 19 (2009) 2924-2927
42. Chang B., Chen Y., Zhao Y., and Bruick R.K. JMJD6 is a histone arginine demethylase. Science 318 (2007) 444-447